Phibro Animal Health Corp (PAHC) Receives $40.33 Average PT from Brokerages

Shares of Phibro Animal Health Corp (NASDAQ:PAHC) have earned a consensus recommendation of “Hold” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $40.33.

A number of brokerages have recently weighed in on PAHC. BidaskClub upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Friday, March 22nd. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, April 29th. ValuEngine lowered Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, February 13th. Guggenheim started coverage on Phibro Animal Health in a research note on Thursday. They set a “neutral” rating on the stock. Finally, Gabelli upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price objective on the stock in a research note on Wednesday, May 8th. They noted that the move was a valuation call.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Advisory Services Network LLC boosted its holdings in shares of Phibro Animal Health by 20.4% during the 4th quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock valued at $71,000 after acquiring an additional 372 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Phibro Animal Health by 4.1% during the 4th quarter. Victory Capital Management Inc. now owns 10,756 shares of the company’s stock valued at $346,000 after acquiring an additional 419 shares in the last quarter. Jefferies Group LLC boosted its holdings in shares of Phibro Animal Health by 5.3% during the 1st quarter. Jefferies Group LLC now owns 8,578 shares of the company’s stock valued at $283,000 after acquiring an additional 433 shares in the last quarter. Algert Global LLC boosted its holdings in shares of Phibro Animal Health by 1.6% during the 4th quarter. Algert Global LLC now owns 28,849 shares of the company’s stock valued at $928,000 after acquiring an additional 464 shares in the last quarter. Finally, Quantamental Technologies LLC boosted its holdings in shares of Phibro Animal Health by 26.0% during the 1st quarter. Quantamental Technologies LLC now owns 2,358 shares of the company’s stock valued at $78,000 after acquiring an additional 487 shares in the last quarter. 50.87% of the stock is currently owned by institutional investors.

Shares of NASDAQ PAHC traded down $0.03 during trading hours on Friday, reaching $29.74. 210,000 shares of the stock were exchanged, compared to its average volume of 167,047. The firm has a market cap of $1.20 billion, a P/E ratio of 17.09, a price-to-earnings-growth ratio of 4.35 and a beta of 0.63. The company has a current ratio of 3.41, a quick ratio of 1.98 and a debt-to-equity ratio of 1.48. Phibro Animal Health has a 52 week low of $28.26 and a 52 week high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, May 6th. The company reported $0.39 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.04). The firm had revenue of $205.70 million for the quarter, compared to the consensus estimate of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. Phibro Animal Health’s revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter last year, the business posted $0.46 EPS. Analysts forecast that Phibro Animal Health will post 1.52 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 5th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.61%. The ex-dividend date of this dividend is Tuesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is 27.59%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: How is a Moving Average Calculated?

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.